Application Nr Approved Date Route Status External Links
ANDA200823 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Pioglitazone And Metformin Hydrochloride Tablets Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus When Treatment With Both Pioglitazone And Metformin Is Appropriate [See Clinical Studies (14) ] . Pioglitazone And Metformin Hydrochloride Tablets Are A Thiazolidinedione And Biguanide Combination Product Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus When Treatment With Both Pioglitazone And Metformin Is Appropriate. (1 , 14) Important Limitations Of Use: Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. (1) Important Limitations Of Use Pioglitazone Exerts Its Antihyperglycemic Effect Only In The Presence Of Endogenous Insulin. Pioglitazone And Metformin Hydrochloride Tablets Should Not Be Used To Treat Type 1 Diabetes Or Diabetic Ketoacidosis, As They Would Not Be Effective In These Settings. Use Caution In Patients With Liver Disease [See Warnings And Precautions (5.5) ] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments